Jefferies Maintains a 'Hold' on Sequans Communications (SQNS); 4Q Preview
Get Alerts SQNS Hot Sheet
Price: $0.51 +2.00%
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Join SI Premium – FREE
Jefferies maintains a 'Hold' on Sequans Communications (NYSE: SQNS) price target halved to $3.00.
Jefferies analyst said, "SQNS is cheap but hard on the eye (serial warnings) and at the mercy of market dynamics near term – at least the WiMAX sales collapse ("zero" US sales into FY12) is well-flagged as shipments are almost halted at one US customer. Yet this much 4G experience can’t go unnoticed by predators. With questionable 2012 WiMAX volumes and LTE 12+ months off, we maintain our Hold but cut our PT."
Jefferies lowers Q4 EPS estimate range to -$0.17 to -$0.18 for 4Q11 (previous guidance -$0.05 to -$0.01.
For an analyst ratings summary and ratings history on Sequans Communications click here. For more ratings news on Sequans Communications click here.
Shares of Sequans Communications closed at $3.45 yesterday.
Jefferies analyst said, "SQNS is cheap but hard on the eye (serial warnings) and at the mercy of market dynamics near term – at least the WiMAX sales collapse ("zero" US sales into FY12) is well-flagged as shipments are almost halted at one US customer. Yet this much 4G experience can’t go unnoticed by predators. With questionable 2012 WiMAX volumes and LTE 12+ months off, we maintain our Hold but cut our PT."
Jefferies lowers Q4 EPS estimate range to -$0.17 to -$0.18 for 4Q11 (previous guidance -$0.05 to -$0.01.
For an analyst ratings summary and ratings history on Sequans Communications click here. For more ratings news on Sequans Communications click here.
Shares of Sequans Communications closed at $3.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sea Ltd. (SE) PT Raised to $85 at Jefferies; 'Solid Execution Across Different Segments'
- Fiserv (FI) PT Raised to $175 at TD Cowen
- BMO Capital Reiterates Outperform Rating on Beam Therapeutics Inc (BEAM)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!